Literature DB >> 29660433

Slit2-Robo2 signaling modulates the fibrogenic activity and migration of hepatic stellate cells.

Zhiping Zeng1, Yujing Wu1, Yirong Cao1, Ziying Yuan1, Yuanqing Zhang1, David Y Zhang2, Daisuke Hasegawa2, Scott L Friedman2, Jinsheng Guo3.   

Abstract

BACKGROUND & AIM: Slit/Robo signaling was originally identified as a repulsive guidance cue in regulating axon branching and neuronal migration. Hepatic stellate cells (HSCs) are the key fibrogenic cells in the liver, which are migratory when activated, and express neural crest markers. The aim of the present study was to investigate the functional significance of Slit/Robo signaling in liver fibrogenesis and in HSCs. KEY
FINDINGS: By transcriptomic analysis it was found that axon guidance signaling pathways were significantly upregulated in both diethylnitrosamine (DEN) and thioacetamide (TAA)-induced experimental liver fibrosis. The up-regulation of the ligand Slit2 and membrane receptor Robo2 genes within this pathway was further validated in TAA-induced fibrotic livers. By immunofluorescence staining, Robo2 was localized in fibrotic septa of fibrotic liver and on the surface of HSCs. By Western blot analysis, recombinant Slit2 (rSlit2) was found to promote fibrogenic protein expression in JS1 cells, an immortalized mouse HSC line, while activating PI3K/Akt signaling pathway. This effect was abrogated by LY294002, a PI3K/Akt pathway inhibitor. In addition, rSlit2 stimulation markedly inhibited JS1 cells migration in transwell migration assays, which was abrogated by small interfering RNA (siRNA) knockdown of Robo2 in the cells. SIGNIFICANCE: The present study provides evidence that Slit2/Robo2 signaling mediates the pathogenesis of hepatic fibrogenesis and regulates HSCs biology, thus providing potential markers for HSCs, and therapeutic and diagnostic target toward liver fibrosis.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cell migration; Hepatic stellate cells; Liver fibrosis; Robo2; Signaling pathway; Slit2

Mesh:

Substances:

Year:  2018        PMID: 29660433      PMCID: PMC6322547          DOI: 10.1016/j.lfs.2018.04.017

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  6 in total

1.  Transcriptional regulation of alcohol induced liver fibrosis in a translational porcine hepatocellular carcinoma model.

Authors:  Alvi Yasmin; Daniel P Regan; Lawrence B Schook; Ron C Gaba; Kyle M Schachtschneider
Journal:  Biochimie       Date:  2021-01-12       Impact factor: 4.079

2.  Peripheral blood proteomic profiling of idiopathic pulmonary fibrosis biomarkers in the multicentre IPF-PRO Registry.

Authors:  Jamie L Todd; Megan L Neely; Robert Overton; Katey Durham; Mridu Gulati; Howard Huang; Jesse Roman; L Kristin Newby; Kevin R Flaherty; Richard Vinisko; Yi Liu; Janine Roy; Ramona Schmid; Benjamin Strobel; Christian Hesslinger; Thomas B Leonard; Imre Noth; John A Belperio; Scott M Palmer
Journal:  Respir Res       Date:  2019-10-22

3.  Soluble TREM-1, as a new ligand for the membrane receptor Robo2, promotes hepatic stellate cells activation and liver fibrosis.

Authors:  Ting Liu; Shujia Chen; Xiaoli Xie; Hongqun Liu; Yongjuan Wang; Shengbin Qi; Linping Shi; Xue Zhou; Jiuna Zhang; Shuling Wang; Yijun Wang; Shengxiong Chen; Shiying Dou; Xiaoyu Jiang; Ruolin Cui; Huiqing Jiang
Journal:  J Cell Mol Med       Date:  2021-11-09       Impact factor: 5.310

4.  Crosstalk between the activated Slit2-Robo1 pathway and TGF-β1 signalling promotes cardiac fibrosis.

Authors:  Yunqi Liu; Ziwei Yin; Xueqin Xu; Chen Liu; Xiaoying Duan; Qinlan Song; Ying Tuo; Cuiping Wang; Jing Yang; Shengli Yin
Journal:  ESC Heart Fail       Date:  2020-11-24

5.  Identification of Liver Immune Microenvironment-Related Hub Genes in Liver of Biliary Atresia.

Authors:  Jiaxu Zhang; Yi Luo; Mingxuan Feng; Qiang Xia
Journal:  Front Pediatr       Date:  2022-01-17       Impact factor: 3.418

6.  Association of Circulating Proteins with Death or Lung Transplant in Patients with Idiopathic Pulmonary Fibrosis in the IPF-PRO Registry Cohort.

Authors:  Jamie L Todd; Megan L Neely; Robert Overton; Hillary Mulder; Jesse Roman; Joseph A Lasky; Joao A de Andrade; Mridu Gulati; Howard Huang; Thomas B Leonard; Christian Hesslinger; Imre Noth; John A Belperio; Kevin R Flaherty; Scott M Palmer
Journal:  Lung       Date:  2022-01-23       Impact factor: 2.584

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.